Metropolis Q1 revenue up ~16% but growth slows from Q4's 23.6%
Wellness and specialty segments drive volumes; EBITDA margins improve YoY and stay stable sequentially. Full results await board approval.
What's new
- Consolidated revenue grew ~16% YoY, slower than Q4FY26's 23.6% growth.
- TruHealth Wellness and Specialty segments are the fastest growing.
- B2C and B2B volumes both rose; EBITDA margins improved YoY and were stable QoQ.
Why this matters
The deceleration from Q4's pace is notable, but margin improvement suggests cost discipline. With no absolute figures, the audited results will determine whether the slowdown is seasonal or structural.
What we're watching
- Full Q1FY27 financials with absolute revenue and profit numbers.
- Segment-level profitability, especially for Wellness and Specialty.
- Whether B2B wallet share gains continue to offset B2C seasonality.
The full read
Metropolis Healthcare's Q1FY27 business update shows revenue growing ~16% year-on-year, driven by patient volumes and a favourable product mix. That is a deceleration from Q4FY26's 23.6% growth, but EBITDA margins improved YoY and held steady QoQ – a sign of cost discipline. The fastest growth came from the TruHealth Wellness and Specialty segments, while both B2C and B2B channels posted higher volumes. The filing is a routine early glimpse: no absolute numbers, no guidance revision. The open question is whether the slowdown is seasonal or structural. Full results after board approval will tell.
Questions answered
- How does Q1FY27 revenue growth compare with the previous quarter?
- Q1FY27 revenue grew ~16% YoY, down from Q4FY26's 23.6% YoY growth. The company did not provide sequential growth numbers.
- Which segments drove the growth?
- The TruHealth Wellness and Specialty segments were the fastest growing. B2C volumes benefited from an expanded centre network, while B2B volumes grew through higher wallet share and new customer acquisitions.
- Did profitability improve?
- Yes, EBITDA margins improved year-on-year and remained largely stable compared to the previous quarter. Absolute EBITDA figures will be released with audited results.
- Is this business update in line with market expectations?
- The analyst rationale notes that the update is largely in line with expectations, as the growth trajectory and margin trends are consistent with recent quarters. No surprise or material deviation was flagged.
- When will the full Q1FY27 results be available?
- The company stated that detailed financial results will be disclosed after review by the auditors and approval by the board. No specific date was given.